CHESTGuidelines & Topic CollectionsSepsisRapid Diagnostics for Infectious Diseases in the ICU

Rapid Diagnostics for Infectious Diseases in the ICU

Traditional cultures are the gold standard for diagnosing infection but are limited by sensitivity and can require days to give results. Newer molecular methods may be able to identify pathogens and drug resistance more rapidly.

Compiled by the CHEST Sepsis Resources Steering Committee

Last updated May 26, 2023

Multiplex PCR Panels

Commercially available assays used to diagnose CNS, lower and upper respiratory infections
Provide semiquantitative detection of multiple viral and bacterial pathogens
Detect some common genetic markers for antibiotic resistance (eg, beta-lactams)
60%-75% detection rates vs 44% for standard culture

Rapid Blood Culture Identification Systems

Faster results than conventional blood cultures, which need 48-72 hours
Used to detect key genes from positive blood cultures
Unlike PCR, lacks an amplification step, so a threshold quantity of bacteria is needed
Detects some common beta-lactam resistance genes

MALDI-TOF

Uses mass spectrometry to provide rapid species identification of positive cultures
Results 24-28 hours faster than traditional biochemical methods
Currently cannot provide antibiotic susceptibility results
Some “species” cannot be differentiated (eg, E coli and Shigella)

Next-Generation Sequencing (NGS)

Measurement of circulating pathogen cell-free DNA from human plasma
Potentially yields very rapid results
Not pathogen-specific, unlike PCR
Observational study in Germany found 72% of patients with septic shock had positive NGS results vs 33% with positive cultures ➔ 53% of findings could lead to changes in therapy! (Grumaz, et al. Crit Care Med. 2019.)

This resource was supported by Grant/Cooperative Agreement Number 5 NU50CK000604-02-00 from the Department of Health and Human Services, Centers for Disease Control and Prevention. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Health and Human Services, Centers for Disease Control and Prevention.